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Chapter 1.
Site-Directed Mutagenesis of Conserved Amino Acids Residues in N5Carboxyaminoimidazole Ribonucleotide Mutase: converting N5-CAIR into
Aminoinmidazole Ribonnucleotide carboxylase
1.1.

Introduction

1.1.1. The role of purine nucleotides in cellular activity
Purine nucleotides play an important cellular role. They are utilized in
energy storage (ATP), the synthesis of cofactors (NADH, B-12) and in the
synthesis of amino acids and secondary natural products. Given the
importance of purines to the cell, it is not surprising that two pathways exist for
their synthesis, namely the salvage and de novo biosynthetic pathways.1,2
1.1.2. Salvage pathway
The salvage pathway is a “recycle” pathway, where free bases
generated from the degradation of nucleic acids are used to prepare new
nucleotides through multiple enzymes. There are two critical enzymes which
are commonly used. Adenine phosphoribosyltransferase (APRT) catalyzes the
attack of free adenine onto 5-phosphoribosyl-α-pyrophosphate (PRPP) to yield
AMP and PPi (Scheme 1

Salvage pathway A). The other enzyme is

hypoxanthine-guanine phosphoribosyltransferase (HGPRT) which catalyzes a
similar reaction to transfer guanine to PRPP to generate GMP (Scheme 1
Salvage pathway C). This enzyme also catalyzes the reaction of hypoxanthine

with PRPP to give IMP (Scheme 1 Salvage pathway B).3
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Scheme 1 Salvage pathway

The amount of purine nucleotides prepared by the salvage pathway is
about 1%, so the pathway is utilized predominately for cellular stasis. For cells
undergoing division, new purine nucleotides must be created. They are
synthesized from the de novo purine biosynthetic pathway.4
1.1.3. De novo purine biosynthetic pathway
Unlike the salvage pathway, the de novo purine pathway synthesizes
the purine heterocycle from basic building blocks（Figure 1）. In this pathway,
PRPP is the starting substrate that is ultimately converted to IMP. The pathway
is intriguing because of the interesting chemistry which occurs in the pathway
and also because it is one of the few primary metabolic pathway which is
different between microbes and humans.5 The difference is focused on the
conversion

of

aminoimidazole

ribonucleotides

(AIR)

to

4-carboxy-5-

aminoimidazole ribonucleotide (CAIR). In humans, AIR is directly converted to
CAIR by the enzyme AIR carboxylase (Class II PurE), requiring CO2 as the one
carbon substrate. In most bacteria, two steps and two enzymes are needed to
convert AIR to CAIR. Step one is catalyzed by N5-carboxyaminoimidazole
ribonucleotide (N5-CAIR) synthetase (PurK) which converts AIR to N5-CAIR

3

with support of ATP and HCO3-. The second step is the conversion of N5-CAIR
to CAIR catalyzed by N5-CAIR mutase (Class I PurE). 6,7

Figure 1. The de novo purine biosynthetic pathway. The green square
hights the difference between Class I and Class II PurEs found in
microbes versus higher eukaryotes. The enzyme names and
abbreviations of substrates can be found in Tables 1 and 2
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Table 1. Enzymes in de novo purine biosynthetic pathway.
Gene

Enzyme name

PurF

PRPP amidotransferase

PurD

GAR synthetase

PurN

GAR transformylase

PurT

FGAR synthetase

PurL

FGAM synthetase

PurM

AIR synthetase

Class II PurE

AIR carboxylase

PurK

N5-CAIR synthetase

Class I PurE

N5-CAIR mutase

PurC

SAICAR synthetase

PurB

Adenylosuccinate lyase

PurH

AICAR transformylase

PurJ

IMP cyclohydrolase

Table 2. Abbreviation of substrates
Abbreviation of
intermediate
PRPP

Full Name
5-Phosphoribosyl-α-pyrophosphate

PRA

5-Phosphoribosylamine

GAR

Glycineamide ribonucleotide

FGAR

N-formylglycineamide ribonucleotide

FARM

N-formylglycineamidine ribonucleotide

AIR

Aminoimidazole ribonucleotide

N5-CAIR

N -Carboxyaminoimidazole ribonucleotide

CAIR

4-Carboxy-5-aminoimidazole ribonculotide

SAICAR

Succino 5-aminoimidazole-4-carboxaminde ribonucleotide

AICAR

Aminoimidazole-4-carboxamide ribonucleotide

FAICAR

5-Formamido-4-imidazolecarboxamide ribonucleotide

IMP

Inosine monophosphate

5
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1.1.4. PurK
PurK is one of the ATP-grasp enzymes and its active site includes ATP,
AIR and bicarbonate subsites.8 As mentioned above, PurK catalyzes the
turnover of AIR to N5-CAIR. This is an ATP-dependent process and links CO2
to the N5 amino group on AIR to generate N5-CAIR. However, PurK is not
required under the condition of high CO2 concentration as AIR can be nonenzymatically converted to N5-CAIR without the support of ATP.9
1.1.5. N5-CAIR
N5-CAIR had not been known as an intermediate in the pathway until
the 1990s. This is likely due to the fact that it is a highly unstable compound. It
is sensitive to pH and temperature. At 30 ºC and pH 7.8, the half-life of N5CAIR is about 0.9 minutes, where it ready breaks down to AIR.10 The low
stability has important implication for how bacteria handle this metabolic
intermediate in the middle of a biosynthetic pathway.
1.1.6. Class I and Class II PurEs
Previous studies have shown that the Class I and Class II PurEs are
evolutionarily related to each other. Each catalyzes a reversible reaction to
generate the same product, CAIR. In addition, both have extremely similar
protein structures (Figure 2), and shared about 20-30% sequence identity with
each other.11 Despite these similarities, there exist critical differences between
these two classes of PurEs.
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1.1.6.1.

AIR is the substrate of Class II PurEs but not Class I PurEs

When AIR is incubated with Class II PurEs in the presence of CO2, rapid
CAIR formation is observed.12 In contrast, addition of N5-CAIR or PurK (to
produce N5-CAIR in situ) fail to give a burst of CAIR formation.9 NMR studies
on the conversion of CAIR by the Class II PurEs fail to detect any N5-CAIR and
instead yield AIR.13
1.1.6.2.

N5-CAIR is the substrate of Class I PurE but not Class II PurE

NMR spectroscopy was applied to investigate and analyze the reverse
reaction of CAIR with Class I PurE. NMR analysis showed that CAIR is first
converted into N5-CAIR which is then non-enzymatically converted to AIR.10
This is a strong evidence that Class I PurE catalyzes N5-CAIR rather than AIR
to form CAIR. Addition of CO2 to AIR and Class I PurE gives a decrease in
absorbance (due to N5-CAIR formation) followed by an increase in absorbance
due to CAIR formation. This study indicates that N5-CAIR, not AIR and CO2,
are substrates for Class I PurEs. 13

7

P
S

Figure 2 Crystal structure of Class I and Class II PurEs structures. (A)Human
PAICS (PBD 2H31) contains Class II PurE active sites and SAICAR synthetase
active sites; (B) E.coli PurE (PBD 2ATE).(C) Superposed monomer structures of
Class I (yellow) Class II (blue)PurE
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1.1.7. Sequence and structural studies

Figure 3. Sequence alignments between Class I and Class II PurEs. (A)
Alignments between E.coli PurE and G.gallus PurE. Red cubes indicate
universal conserved residues, and blue cubes indicates class specific
residues. Sequence numbered after E.coli PurE. (B) Sequence alignments in
40S and 70S loop numbered after Td PurE. Orange represent the universal
conserved residues, green is Class I specific conserved residues, and blue is
Class II specific conserved residues. Td is Treponema denticola; Af is
Archaeoglobus, fulgidus; Aa is Acetobacter aceti; Ec is Escherichia coli
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Previous studies of Class I and Class II PurEs have shown how similar
these two enzymes are to one another. The crystal structures (Figure2) show
that they are both symmetrical octamers formed by similar 17KD subunits.14,15
In humans, Class II PurEs are fused with SAICAR synthetase (PurC), while
bacterial Class I PurEs are usually expressed alone. For yeast and fungi, Class
I PurEs are usually fused with PurK. The sequence alignment of Class I and II
from different species indicates that both have several conserved regions
(Figure 3A). P-loop, which is between the β1 and α1, is responsible for
phosphate group. 40s loop is located between β2 and α2, and 70s loop is
located between β3 and α3.14,16 Sequences alignments of Class I and II PurEs
in the 40s and 70s loops indicates that S38, A39, H40, A66, G67, and L72 are
highly conserved amino acid residues for all PurEs (Figure3 B). However,
there are residues which are only conserved in each class. In the 40s and 70s
loop, Class I PurEs’ residues are conserved in R41, G68, A69, A70, H71,P73,
while most Class II PurEs have K41, G68, S69, N70, G71,S73 at the same
residues.11,15 One of the special case of Class II PurEs is Treponema denticola
(Td) PurE, which is the only known bacterial AIR carboxylase.16
The question of how these two similar enzymes catalyze different
reactions is still unknown. The hypothesis is that the class specific conserved
residues might be the key to determining the functional differences between
these two classes of enzymes. However, few studies have been done on these
residues and we don’t know which residues are important for the specificity of
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the reaction. To investigate this issue, we conducted site-direct mutagenesis to
convert conserved amino residues (41, 68, 69, 70, 71, and 73) of wild type
Escherichia coli into residues which mimic those found in Class II PurEs.
Mutants were then investigated to determine, which, if any, mutation produced
a change in the specificity of the enzyme reaction.
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1.2.

Results
The previous study of crystal structures of PurE shows that the active

sites of PurEs are located in the P, 40s and 70s loops. Since the conserved
residues on the P-loop are universally conserved, we did not alter these
residues.15 We focused on the class-specific conserved residues found in the
40s and 70s loops to investigate whether these residues affected the functional
divergence between the two classes of PurEs.16
Arg41, Gly68, Ala69, Ala70, His71 and Pro73, (numbered by Td PurE,
(Fiugre 3B), are Class I PurE conserved residues and we mutated each of
these residues to that found in the human region.a This gave mutants R41K,
G68R, A70N, H71G and P73S. Since T.denticola PurE is a bacterial Class II
PurE we also mutated His 71 to alanine.
We investigated each of these mutants using developed assays, and
compared them to the same kinetic studies of WT E.coli PurE. These studies
were done to determine which amino acid(s) will decide the functional
divergence between the two classes of PurEs.
1.2.1. Enzyme expression and purification
The cloning of PurE and plasmid purification was done by Aiko Hirata.
The single mutants made are R41K, G68R, A70N, H71A, H71G and P73S. All
plasmids were transformed into BL21/(DE3) competent cell for protein
expression. All proteins were expressed and purified according to previously
a

All the mutants cloning was done by Aiko Hirata from Dr. Fusao Hirata’s group
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developed procedures.17 SDS-PAGE was utilized to check the protein
purification of mutants. We obtained purified mutants R41K, G68R, A70N,
H71A, and H71G. The P73S PurE, however, couldn’t be expressed and was
therefore not purified.
1.2.2. Protein folding of mutants
1.2.2.1.

Limited proteolysis for WT and mutant PurEs

In order to check whether the mutants are folding properly, limited
proteolysis assays were performed. It is expected that a correctly folded
enzyme will be relatively stable to the serine protease, subtilisin, whereas an
unfolded protein would be degraded completely.18,19 As showed in Figure 4,
incubation of WT PurE with subtilisin for 1 hour leads to only a modest
digestion as indicated by bands below the WT protein. This indicates that the
protease only partly digests wild-type PurE. Analysis of mutants R41K, G68R,
H71G and H71A with protease showed a pattern qualitatively similarity to the
WT PurEs. However, A70N gave complete digestion indicating that this protein
is partially unfolded or adopts an alternative conformation.
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Lander

1

2

3

4

5

6

7

8
Subtilisin

35kD
25kD
15kD

10kD

Lander

9

10

11

12

Subtilisin

35kD
25kD

15kD

10kD
1
2
3
4
5
6

WT PurE
WT PurE + Subtilisin
R41K
R41K + Subtilisin
G68R
G68R + Subtilisin

7
8
9
10
11
12

A70N
A70N+ Subtilisin
H71A
H71A + Subtilisin
H71G
H71G+ Subtilisin

Figure 4 SDS-PAGE (15%) of 18 µg of wild-type or mutant (17kD) PurEs
incubated with 18 µg subtilisin (27kD) for 1 hour. The reaction were stopped
by addition of PMSF. Gel were photographed and the contrast was adjusted to
provide the image seen here
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1.2.2.2.

Circular dichroism spectrum for folding of mutants

Figure 5 Far-UV CD spectra of H71G and Wild Type PurE in 100 mM
Na3PO4 (pH, 7.4). The blue line represents 1.24 mg/mL of wild type PurE,
while the red line is 1.15 mg/mL H71G.

Circular Dichrosim (CD) can provide information on the structure of a
protein. Usually, two UV regions are tested, the far-UV and near-UV. The
absorption in the far-UV region (180nm-240nm) are mainly due to protein
secondary structure (α-helix, β-sheet, etc.), while the near-UV (250nm290nm), where aromatic side chains can be detected, usually help to
determine the tertiary protein structures.20,21
The far-UV CD spectra showed that no significant change of H71G
secondary structure compared to WT PurE (Figure 5). Near-UV CD spectrum
gave, no significant data for either WT PurE or H71G PurE. This result
indicates that the H71G mutant is folded properly.
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1.2.3. Steady-State kinetic analysis of the PurE mutants
The steady-state kinetic analysis for both WT and mutant PurEs was
conducted using the CAIR decarboxylation assay.12 Kinetic constant were
determined by curve fitting a plot of velocity versus CAIR concentration to the
Michaelis Menten equation.22
Table 3 Steady-State Kinetic Constants for Wild-type PurE and Mutants. Vmax and
Km was determined by the CAIR decarboxylation assay system; kcat was
calculated using the molecular weight of the octamer.
PurE Mutants

Vmax
-1
-1
(μmol·min ·mg )

Km
（μM）
μM）

kcat
（min-1）

relative kcat/Km
(units/mg)

kcat/Km
-1
-1
min ·M )

Wild type

54

38

7297

1

1.9X10

8

G68R

19

32

2538

0.35

7.9X10

7

A70N

0.6

473

75

0.01

1.6X10

5

H71G

6

16

800

0.11

5.0X10

7

H71A

8

15

1111

0.15

7.4X10

7

R41K

1.5

37

204

0.03

5.5X10

6

As shown in Table 3, the catalytic proficiency of all mutants, as
expected, are decreased about 3-100 fold. Since A70N is not folded properly, it
is not surprising to see its low binding affinity and catalytic proficiency. The Km
values are all within 2-fold of WT PurE suggesting that these mutants do not
affect CAIR binding. The kcat/Km of WT and mutant PurEs are again similar.
Overall, the kinetic studies indicate that these residues do not play a major role
in either substrate binding or catalysis. Such a result may be expected give the
fact that we made changes of conserved residues to amino acids that were
conserved in the other class of PurE. A key question, though, is whether these
mutants catalyze a different reaction from WT Class I PurE.
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1.2.4. Comparison of the CO2 dependence of wild type PurE, human AIR
carboxylases and mutant PurE
Previous studies have shown that CO2 is the substrate only for AIR
carboxylase. Class I PurEs are independent of the one-carbon substrate.
However, N5-CAIR synthesis can occur non-enzymatically if enough CO2 is
provided. Therefore, one way to distinguish Class I and Class II PurEs (AIR
carboxylase) is by examining their dependence on CO2.14
To determine this, reactions are examined at 10 ºC, where the rate of
equilibrium between CO2 and HCO3- is decreased. Thus, at early time points,
the predominant one-carbon species is the one added. When CO2 is added,
AIR carboxylases rapidly converts AIR to CAIR.12 Addition of bicarbonate gives
no conversion. In contrast, when AIR is incubated with Class I PurE and CO2,
no burst is observed.13 In fact, often a decrease in absorbance is seen.23 This
decrease is due to the non-enzymatic turnover of AIR to N5-CAIR. At later
times, CAIR production is seen as an increase in absorbance.
As shown in Figure 6, addition of CO2 to WT PurE (blue line) generates
a curve which shows a lag followed by an increase of CAIR production.
Addition of CO2 to human AIR carboxylase (yellow line) gave a burst in CAIR
formation. These results were used as controls for mutants. Incubation with
bicarbonate, results in no or modest CAIR formation for either WT PurE, AIR
carboxylase or the mutants (Figure 7).
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Figure 6. 150 µm AIR incubated with wild type or mutants PurE in the
presence of 20 mM CO2. Yellow line is the absorbance of 600 ng human
AIR carboxylase incubated with CO2, blue line is the 180ng E.coli PurE
incubate with CO2. Red line shows each mutants with CO2 20 mM with
same specific activity (0.01µm·min-1). For comparison, the data for WT
PurE and AIR carboxylase is shown with each mutant. (A) G68R 800 ng;
(B) A70N 27 µg; (C) H71G 1.3 µg (D) H71A 1.2 µg (E) R41K 5.8 µg
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Figure 7. Comparaison of WT and mutant PurEs with CO2 or HCO3-. Orange
lines represent enzymes incubated with 20mM CO2, green lines are enzymes
with 20 mM HCO3-. (A) Wild-type PurE 180ng (B) Human AIR carboxylase 600
ng ; (C) R41K 5.8 µg; (D) G68R 800 ng; (E) A70N 27 µg; (F) H71G 1.3 µg ;(G)
H71A 1.2 µg.
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G68R, R41K and A70N all show obvious delays(Figure 6)when
incubated with CO2. This indicates that CO2 is not a substrate for these three
mutants.
H71G shows a burst upon the addition of CO2 and a slow increase when
HCO3- added. This is very similar to the curve generated with AIR carboxylase
(Figure 7 B&F) with CO2. In addition, it is interesting that the rate of CAIR
production is greater than for human AIR carboxylase. In order to verify that
CO2 was a substrate for H71G, carbonic anhydrase was introduced into the
assay. Carbonic anhydrase rapidly establishes the equilibrium between CO2
and bicarbonate.24

As showed in Figure 8, in the presence of carbonic

anhydrase, the rate of CAIR production incubated with CO2 decreases due to
rapid conversion of CO2 to bicarbonate. In contrast, incubation of H71G with
bicarbonate and carbonic anhydrase leads to an increase in rate of CAIR
production. This evidence shows that CO2, but not HCO3-, is the substrate for
H71G.

Figure 8 Mutation H71G with one-carbonate substrates incubated with
1 µg carbonic anhydrase.
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H71A is another interesting mutant. Incubation with CO2 does not
generate a burst, however CAIR production is much more rapid than for WT
PurE. Incubation with HCO3- curve indicates that HCO3- is not the substrate for
H71A. Thus, H71A appears to be a hybrid between Class I and Class II
PurEs.The analysis of the use of CO2 as a substrate revealed that H71G and
perhaps H71A could utilize CO2. This is a hallmark trait of AIR carboxylase and
suggests that H71G may be an AIR carboxylase enzyme. However, these
experiments do not indicate whether H71G has the ability to still utilize N5CAIR as a substrate.
1.2.5. The PurC-coupled assay
In order to determine whether AIR or N5-CAIR is the substrates for
H71A and H71G, we used a PurK/PurC coupled assay (Figure 9). This assay
was done to produce N5-CAIR in situ and to make CAIR production irreversible
by converting it to SAICAR. SAICAR production is monitored at 282nm to
indicate the production of CAIR.13 In the absence of PurK (Figure 10 A), almost
no SAICAR is produced from AIR by WT E.coli PurE. In addition, this
demonstrates that the non-enzymatic synthesis of N5-CAIR is not sufficient for
turnover. This indicate that AIR, as expected, is not a substrate for WT PurE.
In the contrast, addition of H71G or H71A gave an increase in SAICAR
production, showing the AIR converted to CAIR in the absence of its
conversion to N5-CAIR by PurK.
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Figure 10 PurC coupled assay

Figure 10 PurC coupled assay to monitor N5-CAIR turnover. Green lines are
325 ng WT PurE; Yellow lines are 2 µg H71A; Red lines are 3 µg H71G. (A)
Enzymes incubated without PurK; (B) enzymes incubated with 1.1 µg PurK.
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Addition of excess PurK leads to the rapid conversion of AIR in to N5CAIR, and consequently, SAICAR is produced rapidly with WT PurE (Figure 10
B, green line). This validates that N5-CAIR is the substrate of PurE.
Interestingly, H71G also gave a bust of SAICAR production in the presence of
PurK (Figure 10B, red line). The rate, however is lower than WT PurE. H71A
shows a large burst of SAICAR production and appears it be faster than for WT
PurE (Figure 10B, yellow line).
These results indicate that AIR is a substrate for both H71A and H71G.
However, each protein also appears to utilize N5-CAIR as a substrate. Thus,
H71A and H71G are both AIR carboxylase and N5-CAIR mutase enzymes.
This data suggests that His71 plays a critical role in the reaction specificity of
these enzymes.
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1.3.

Discussion
The purpose of the site-directed mutagenesis of N5-CAIR mutase is to

find possible amino acid residues that might determine the functional
divergence between Class I and Class II PurEs. Therefore, the residues
chosen in this study are in the active sites of both Class I and II PurEs and,
also, are specifically conserved in each type of PurE. We then mutated E.coli
PurE conserved residues in the 40s and 70s loop to the corresponding
conserved residues in human AIR carboxylase. We also mutated His71 to
alanine because it is found in the only known bacterial AIR carboxylase,
Treponema denticola PurE.16 For these studies, we were able to express and
purify, mutants R41K, G68R, A70N, H71G and H71Ab.
We examined the steady-state kinetics using CAIR which is a substrate
for both classes of PurE. All mutants, except for A70N, are active with kcat
values between 2 to 35 folded lower than WT E.coli PurE. Km values are
roughly the same as WT PurE. A70N was excluded as it is folded incorrectly
and its catalytic ability and binding affinity was very low. The kinetic studies
indicated that the enzymes were active, but the assay could not provide
information on what product, AIR or N5-CAIR, is produced from CAIR. Thus,
the study could not determine whether the mutants are N5-CAIR mutases or
AIR carboxylase.

b

All numbered after the T. denticola PurE sequences
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A key difference between N5-CAIR mutase versus AIR carboxylase is
the fact that AIR carboxylase uses CO2 as a substrate and N5-CAIR mutase
does not. Therefore, we evaluate whether CO2 was a substrate for the mutants.
All mutants were studied at the same specific activity to ensure that any burst
of CAIR production was due to CO2 and not elevated enzymes level. The
experiments were also run at 10 ºC to slow the kinetics of the CO2/HCO3equilibrium. The results indicates that H71G and maybe H71A utilized CO2 as
a substrate. This suggests that these mutants are AIR carboxylase.
The next question is whether N5-CAIR is still a substrate. To answer that
question, we utilized the PurC coupled assay investigating the forward reaction.
In this assay, PurC is added, in the presence or absence of PurK, to monitor
CAIR synthesis via SAICAR production. In the absence of PurK, H71G and
H71A produced SAICAR from AIR and residual CO2. This confirms the AIR
carboxylase activity. However, addition of PurK results in a large burst of
SAICAR production indicating that N5-CAIR is also a substrate. This assay
shows that H71G and H71A can utilize both AIR and N5-CAIR as substrates.
This demonstrates that the H71G and H71A mutants are both N5-CAIR mutase
and AIR carboxylase enzymes.
Based on these studies, His 71 seems to be very interesting residue and
plays an important role in determine the functional divergence between human
and bacteria PurEs.
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1.3.1. Possible mechanism the conversion of N5-CAIR to CAIR.
Scheme 2 Simple mechanistic model for Class I and Class II PurEs

Currently, the most plausible mechanism for Class I PurEs is shown in
Scheme 2. CAIR is first reversibly decarboxylated to the intermediate AIR·CO2
complex which is then reversibly converted to N5-CAIR. Class II PurEs appears
to only catalyze the first reversible conversion, CAIR to AIR·CO2.23,25 Structure
studies on the active site of PurEs show that the aminoimidazole ring of CAIR
is in the hydrophobic pocket of Class I PurE formed by conserved residues
located in the 40s and 70s loops.15 The CO2 generated from CAIR
decarboxylation is believed to bind at the bottom of the active site. Therefore,
mechanistic and structural studies indicate that Class I PurEs can trap CO2 in
the active site for the attacking AIR to produce N5-CAIR. Class II PursE allow
CO2 to dissociate from AIR and, therefore, prevent the production of N5CAIR.14 However, Class II PurEs must also facilitate the binding of CO2 for
CAIR formation. How this occurs is unknown.
1.3.2. What role does His71 play in this mechanism?
Structure studies on Acetobacter aceti PurE (Class I PurE) indicates that
His59 and His89 (TdPurE His40 and His71) are in contact with the His59 and
His89 from their neighboring subunits to form a twofold histidine chain. This
chain is isolated from solvent and it has been speculated that the possible
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function of this chain is to transfer protons from one site.26 Several studies
have been done with these two histidine residues. His59 is a universally
conserved residues in both Class I and Class II PurEs and is believed to be the
general base needed for the reaction to form CAIR.14 Site-direct mutagenesis
studies on this residue indicates that it is essential as mutation to other amino
acids abolishes activity.27 On the other hand, our study on His71 agree with
other’s studies which show that site-direct mutagenesis of His71 decreases
the enzyme

activity but the enzyme is still functional.26,27 However,

examination on the reaction catalyzed by this mutant revealed that it has AIR
carboxylase activity. Such a result has not been previously reported.

NAIR
His71
His71

NAIR

Figure 11. Dimer structure of WT Class I PurE (2ATE). His 75 (same as TdPurE
His 71) is shown in red. NAIR is an analogue of CAIR and shown to indicate the
substrate binding site in the active site position.
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Based on the previous mechanism and the crystal structures, we
hypothesize that mutating the His71 residue leads to the opening
ing of a channel
between the two active sites from two monomers in the PurE octamer. The
open channel between the two active sites may provide an avenue for CO2 to
dissociate from the AIR·CO2 complex. Thus, H71G can partition between either
CO2 escape, leading to the generation of AIR or reaction with CO2 to generate
N5-CAIR.
CAIR. It is important to recognize, however, that the CO2 must also bind to
the H71G as the PurC
rC assay in the absence of PurK, indicated turnover from
AIR. How CO2 binds and what is the driving force for this binding is unclear.
1.3.3. The open channe
channel hypothesis for AIR carboxylase

Scheme 3 Transfer
ransfer model of CO2 from N5-CAIR to AIR

Early studies indicated that N5-CAIR
CAIR was utilized as a carboxylase
intermediate for transferring CO2 and AIR to the PurE active site and the use
of

a

carbamate

was

similar

to

the

biotin
biotin-dependent
dependent

carboxylase

mechanisms.10,28,29 One mechanism for N5-CAIR
CAIR mutase was that N5-CAIR
and AIR both bond to the site and CO2 was transfered from N5-CAIR
CAIR to AIR to
generate AIR and CAIR (Scheme 3). However, structural studies indicate that
the active site of Class I PurE does not have enough space for binding both N5-
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CAIR and AIR. The opening channel, as hypnotized above, may provide a CO2
tunnel between two isolated active sites. Thus, CO2 dissociated from N5-CAIR
in one active site may migrate through the channel to bind AIR in the
connecting active site to produce CAIR. Such a mechanism model indicates
that both N5-CAIR and AIR are substrates for AIR carboxylase. The CO2dependence on the reaction could be explained by the rapid production of N5CAIR which then deliveries the CO2 to the enzyme. N5-CAIR itself would not be
turned over until enough AIR was produced to occupy the other active site.
1.4.

Future Studies
According to the results and discussion above, we make a hypothesis

that His 71 might be the critical conserved residue to determine the functional
different and removal of histidine may open a channel between two actives for
CO2 transferring. Therefore much more studies can be applied to prove that.
Some Crystal structures studies should be done to prove whether the
open channel exist and whether they can let CO2 go through. Also, there are
some mutants have not been made properly, which might also important to
determine or assist His 71 to determine the functional differences.
Further studies on this mechanism will need to be done to validate this
proposed mechanism.
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Chapter 2.
Developing a High-Throughput Screening Assay for the Discovery of N5Carboxyaminoimidazole Ribonucleotide Mutase Inhibitors
2.1.

Introduction

2.1.1. Drug Resistance and new antibiotics
Since the 1970s, only two new classes of antibiotics (Linezolid, and
Daptomycin) have been introduced to the market.30 However, infections due to
resistant organisms have become much worse.31,32 Therefore, there is an
urgent need for new targets of antibiotics.
2.1.2. PurEs as a new target for antibiotic drug discovery
The de novo purine biosynthetic pathway could be a potential target for
the development of new antibiotics because the pathway is different between
humans and bacteria.5 As mentioned in the first part of the thesis, Class II
PurEs, found in humans, directly catalyze the conversion of AIR to CAIR, while
Class I PurE, found in bacteria, turns N5-CAIR to CAIR.6 While Class I and
Class II PurEs are similar, they each catalyze their own reaction and selective
inhibition by NAIR suggests that small molecules can be found which can
selectively inhibit one class over other.33 Therefore, PurEs could be a new
antimicrobial drug target.
2.1.3. High-throughput screening
High-throughput screening (HTS) is utilized in drug discover, because it
can screen thousands of compounds in a short period and can provide
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potential “hits” for follow-up studies.34 Critical to the success of a HTS is a
robust and rapid assay which is capable of detecting enzyme catalysis in a
small volume with great sensitivity. A HTS assay must be rapid, sensitive and
free from interference by other parts of the assay. A number of techniques
have been used for HTS assay mostly fluorescence, absorbance, FACS and
even imaging.35
2.1.4. Limitation of CAIR decarboxylase assay
Since no small molecule non-nucleotide inhibitors are known for N5CAIR mutase, the Firestine lab conducted a HTS based on the CAIR
decarboxylase assay. While the assay worked, only one selective inhibitor was
found and the assay suffered from false negatives. The possible reason for the
unsuccessful HTS for N5-CAIR mutase inhibitors is the limitations of the CAIR
decarboxylase assay.12 This assay is based on observing an absorbance
change of CAIR at 260nm. Unfortunately, many organic small molecules also
absorb in this region. To circumvent this problem, the absorbance of the
compound was subtracted from each well. However, for highly absorbent
compounds, this often lead to concerns over measuring the small change in
CAIR absorbance due to catalysis. The potential inhibitors might be missed
during the HTS. It is clear that a better HTS assay is needed for screening for
inhibitors of N5-CAIR mutase. In this chapter, we will discuss the assessment
of several potential assays for HTS of N5-CAIR mutase.36
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2.2.

Results and discussion

2.2.1. AIR carboxylation assay
Another classic assay for the study of PurE activity besides CAIR
decarboxylation is the coupled N5-CAIR mutase assay which measures the
conversion of N5-CAIR to CAIR by the production of SAICAR. This assay starts
with AIR which is rapidly converted to N5-CAIR by PurK. Conversion of N5CAIR to CAIR is monitored by SAICAR synthetase at 282 nm or at 340 nm for
ATP assumption.10,13 However, this assay not appropriate for HTS as several
enzymes (PurK, PurC, PK, LDH and NADH) are involved and, therefore, it is
hard to tell if the hits generated from HTS inhibit PurE the coupling enzymes.
Thus, extensive deconvolution would be needed limiting its usefulness for HTS.

Figure 12 Procedure of PurC coupled assay.
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2.2.2. Thermoflour®

Figure 13 Fluorescence intensity versus temperature for unfolding PurEs
in the presence of SYPRO orange (ex=492 nm, em=610 nm).

The thermoflour® assay is based on measuring the changes in the
protein melting temperature (Tm) upon the binding of a ligand (inhibitor).37
Previous studies have shown that binding of small molecules can alter a
protein’s melting temperature, by either stabilizing or destabilizing the folding of
the protein.38 Therefore, compounds which bind to Class I PurEs could
theoretically be screened by this method.
For PurE, we followed the standard assay determined by Nisesn, et al.39
SYPRO orange (ex=492 nm, em=610 nm) is a fluorescent protein dye whose
fluorescence increases when a protein unfolds. We utilized a real-time (RT)PCR instrument to gradually increase the temperature from 25 to 95ºC, while
monitoring the fluorescence. The Tm was determined from the melting curve
by calculating the maximum of the first derivative.
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The melting curve of E. coli PurE is showed on Figure 13. PurE is
stable until approximately 60 ºC at which point the fluorescence intensity
increases rapidly due to the unfolding of PurE. The signal decrease from 75 ºC
to 95 ºC is due to protein precipitation or aggregation. The calculated Tm of
PurE is 68.12± 0.03 ℃, as determined by 8 replicate experiments.

Figure 14 The melting temperature versus the concentration of compounds.
75 µg/ml PurEs incubated with different concentration (0.01 –1 mM) of
compounds. Green line is AIR; Blue compound 1 (IC50=150 µM); Red line is
DMSO.

We next investigated the affect on the Tm as a function of inhibitor
concentration. Figure 14 shows the Tm versus compound concentration. AIR
was used as a positive control, because previous studies have shown that it
binds to PurE.14 As expected, the fluorescence intensity increase as the
concentration of AIR increased. Compound 1 {1-(4-ethoxyphenyl)-3-[(3-
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pyridinylmethyl) amino]-2,5-pyrrolidinedione}studied as these were identified as
binders in a

fragment screening study for PurE inhibitors.40 Preliminary

experiments indicated that DMSO could affect the Tm, and the two compounds
used in this experiment were dissolved in 100% DMSO. Therefore, we also
measured the change in Tm at DMSO concentrations equivalent to what would
be found for these two compounds. As shown in Figure 14, compound 1 and
DMSO show an identical change. This indicates that both of the compounds
have no significant affect on the PurE Tm change.
Why did we fail to measure a change in Tm for compounds which have
been shown to bind to PurE? One possible reason is that the binding between
PurE and these two compounds is not tight enough. Another possibility is that
the Tm of PurE is fairly high, thus changes in the stability of the protein are
small and so difficult to measure. Alternately, at high temperature, binding of
the compound to the enzyme is poor due to the deformation of the binding site.
Ultimately, despite much effort, we were unable to find a condition that allowed
us to detect binding of various compounds by alternation in Tm. Therefore we
abandoned this assay.
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2.2.3. Metal stopping assay
2.2.3.1.

Assay design and hypothesis
Previous studies indicated that metal cations can chelate to CAIR so

tightly that it stops PurE catalysis.41 The tight binding of metals (such as Ni+
and Zn2+) to CAIR suggested that this property may be useful to determine the
concentration of CAIR, which in turn, could lead to a suitable assay for PurE.
Two questions need to be answered before such an assay can be
developed: which metal to use and how to detect the CAIR:metal concentration.
Previous studies indicated that Ni+ and Zn2+ tightly bind to CAIR and, therefore
stop the reaction. Zn2+ was chosen for our experiments as the previous studies
showed that a CAIR:Ni+ complex had poor kinetic stability.41 To measure the
concentration of CAIR-Zn2+, we utilized the Zn fluorescent dye, TSQ. When
TSQ is incubated with Zn2+, a 1:2 complex is formed which is fluorescent
(ex=360nm, em=490nm).42,43 In the presence of a high CAIR concentration,
zinc would bind to CAIR instead of TSQ and the fluorescence would decrease.
Such a competition assay between TSQ, CAIR and Zn2+ could provide a new
assay for PurE. As CAIR decreases, due to PurE activity, more Zn2+ would be
available to bind to TSQ and the fluorescent signal will increase. Using this
method, we can calculate how much CAIR is converted by the enzyme, and,
therefore, deduce the kinetic data for the enzyme. Ultimately, this assay may
be applicable for HTS.
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Figure 15. Zn2+ stops PurE from converting CAIR to AIR. Green line is
60ng PurE incubated with 130 µM CAIR at room temperature; red Line is
when 250 µM ZnSO4 added.

Figure 16. Fluorescent signal scan (ex=360 nm) for Zinc, AIR and CAIR.
Grey line is the buffer (50mM Tris-HCl, PH7), Purple line is 250 µM ZnSO4 in
buffer; orange line is 250 µM CAIR in buffer; Red Line is 250 µM ZnSO4 with
250 µM CAIR in buffer; green line is 250 µM AIR; and blue line is 250 µM AIR
with 250 µM ZnSO4.

37

Figure 17. Wavelength versus fluorescence (ex=360 nm). Green line is 100
µM ZnSO4 incubated with 50 µM TSQ; Red line is when 50 µM CAIR was
added into solution; Blue line is 550 µM CAIR was added.

Figure 18. CAIR concentration versus Fluorescence (ex=360 nm, em=485
nm). CAIR from 0 to 250 µM incubated with 250 µM ZnSO4 in 96 wells plate.
Each concentration of CAIR has 8 duplicates.
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Figure 19 Fluorescent signal scan (ex=360nm) with PurEs. Green line
represent that 250 µM CAIR incubated with 250 µM ZnSO4, Red line is when
250 µM CAIR incubated with 3 µg E.coli PurE for 5 mins, 250 µM ZnSO4 was
added to the mixture.

2.2.3.2.

Experiments and results

Previous studies showed that 250 µm ZnSO4 totally stops E.coli PurE
from converting CAIR to N5-CAIR.41 As shown in Figure 15, once Zn2+ is
added, there is an immediate end to the PurE catalyzed conversion of CAIR to
N5-CAIR. Therefore, we utilized this condition.
Incubation of TSQ with Zn2+ gave the expected fluorescent signal.
However, addition of CAIR failed to decrease the signal. Therefore, we
checked all compounds used in this assay and interestingly, found that Zn2+
plus CAIR generated a strong fluorescent signal at 460nm (Figure 16). This
signal is close to Zn2+:TSQ complex fluorescent peak. Thus, we found that the
Zn2+:CAIR complex interfered with the monitoring of Zn2+:TSQ complex
formation.
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Based on these results, we redesigned the assay, using the Zn2+:CAIR
fluorescent signal to calculate the CAIR concentration. As shown in Figure 16
and Figure 18, as the concentration of CAIR increases the fluorescence
increases linearly. This provides an easy method to calculate CAIR
concentration. In order for this PurE assay to work, AIR must not form a strong
complex with Zn2+ nor must it generate a strong fluorescent signal. As showed
in Figure 16, incubation AIR with Zn2+ yielded a fluorescent signal, but one
with an intensity much lower than CAIR. In addition, the emission peaks are
different between these two complexes; the peak of AIR complex is about 439
nm while the CAIR complex peak shifts to 459 nm.
Despite this preliminary results, experiments with PurE showed that the
assay is not sensitive. As shown in Figure 19, the fluorescent signal change
can only be observed when a large amount of PurE is added. The amount of
PurE needed (3 µg) is about 60 times that used in the decarboxylation assay.
This would require a large amount of enzyme for HTS. In addition, the small
change in signal could make the assay difficult to use in a screening system
where only a modest inhibition is frequently observed. Since the assay is not
sensitive, we decided not to continue to work on this method.
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Chapter 3
Materials and Methods
3.1

Materials
All chemical compounds come from Fisher, Sigma-Aldrich, or Thermo

Scientific. E.coli PurE mutants were prepared in pET-21 with a C-terminal histag and contained additional sequences CTG GAG CAC CAC CAC CAC CAC
CAC. These plasmids were cloned and amplified by Aiko Hirata. Sequences
were verified by the DNA Sequencing Lab at Wayne State University. BL21
(DE3) was obtained from New England Biolab Inc.. E.coli PurC was the kind
gift of Dr. T. Joesph Kappock (Purdue University, West Lafayette). Wild-type E.
coli PurK was expression and purified by Jordan Rantucci.
All UV assays were conducted on a Cary 100 UV-vis spectrophotometer
equipped with a temperature controller. Fluorescence was done using the
Fluoro MAX®-3 with FluorEssence™ software. Circular Dichroism (CD） was
conducted using Jasco J-1500 high performance CD spectrometer and access
to this instrument was kindly provided by Dr. Timothy Stemmler. Thermal shift
assays were conducted using the Mx3005P qPCR System and access to this
instrument was kindly provided by Dr. Olivia Merkel.
3.2

Expression and purification of WT and mutated PurEs
E.coli BL21/(DE3) was transformed with plasmids containing mutants or

wild-type PurEs cloned into pET-21. A single colony was incubated overnight at
37 ºC in 5 ml LB medium with 50 mg/L ampicillin and the overnight culture was
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diluted (1:100) into 500 mL LB medium with 50 mg/L ampicillin and incubated
until an OD600 of 0.5 was obtained. Protein expression was induced by the
addition of 0.1 M IPTG and incubated for an additional 4 hours. Cells were
centrifuged (20,000 rpm) and stored at -20 ºC until use.
For purification, bacterial cells were lyzed by addition of B-PER reagent
(4 mL per gram of pellet, Pierce Biotechnologies) and incubated for 10 min.
The resulting suspension was centrifuged at 20,000 rpm for 60 min (Beckman
ultra-high-speed centrifuge, rotor JA-20) to remove cell debris. The clear
supernatant was treated with streptomycin (5 mg/mL) and incubated for 2
hours before precipitated nucleic acids were removed by centrifugation at
20,000 rpm for 60 min. The supernatant was loaded, at 4 ºC, onto a column
(10 mL) containing Cobalt RAPID RUN™ Agarose Beads (Gold Biotechnology)
which had previously been pre-conditioned with buffer A (10mM sodium
phosphate, 300 mM sodium chloride, and 10 mM imidazole, pH 7.4). The
column was successively washed, at 4ºC, with Buffers A-D (Buffer A containing
either 50 mM (B), 150mM (C), or 400 mM (D) imidazole). Fractions were
collected and the PurE proteins eluted with buffer D. The purity of the protein
was checked with 15% denatured SDS-PAGE. Purified PurE was dialyzed
against 10 mM Tris-HCl, 200 mM NaCl, pH 8 and concentrated to at least 1
mg/mL using an Amicon® centrifugal concentrator. The protein was stored in 80 ºC. Protein concentrations were determined using the Coommassie
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(Bradford) Protein Assay Kit following the manufactures instructions (Thermo
Scientific).36
3.3

Limited Proteolysis
Limited proteolysis was conducted according to previous methods. (18)

Briefly, wild type or mutant PurEs (18 µg) were added to 30 µL of buffer (50
mM Tris-HCl, pH 8.0) and 0.18 µg of subtilisin (from Bacillus licheniformis) was
added. The reaction was incubated on ice for 1 hour at which time it was
quenched by the addition of 1 mM PMSF. Products of the proteolysis were
examined using a 15% denatured SDS-PAGE stained with Commassie Blue.
3.4

Circular Dichroism.
Wild-type or mutant PurE was dissolved in buffer (NaPO4 100mM, pH

7.4) to a final concentration of 1 mg/ml. The protein sample (70-100 µL) was
loaded in a 0.2 mm path length cuvette and the CD spectrum was obtained at
room temperature for far UV (190-250nm) and near UV (260-320nm).44
3.5

Steady-state kinetic
The assay contained 100 mM Tris-HCl (pH8), 6.25-150 µM CAIR and

varied amounts of WT (48ng) or mutant PurEs (0.2-0.6 µg) in final volume of
1mL in a 1cm path length cuvette. (12) The consumption of CAIR was
monitored at 260nm at room temperature. A plot of initial velocity versus
substrate concentration was generated and the data was fitted to the Michaelis
Menten equation (1) and kinetic parameters were calculated by Kaleidagraph
(Synergy).22
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(1)

3.6

CO2-dependence assay
To a stopper-fitted cuvette containing 100 mM Tris-HCl, pH 8, 3U of WT

or mutant PurEs was added along with 125 µM AIR. The reaction was
incubated at 10 ºC for a min. In some experiment, 1µg/mL carbonic anhydrase
was also added. Reaction was initiated by addition of 20 mM CO2 or NaHCO3.
CO2 solutions were prepared by continuous bubbling CO2 into 100mL distilled
de-ionized H2O at 4ºC and the concentration was estimated by the solubility
constant of CO2 (0.2871g/100g of water).13
3.7

PurC coupled assay.
A cuvette with a 1mL final volume containing 100 mM HEPES, pH 7.5

buffer, 20 mM KCl, 6 mM MgCl2, 2 mM PEP, 100 µM ATP, 10mM aspartic acid,
4 U of pyruvate kinase, 17 U lactate dehayrogenase and 100 µM NADH was
incubated at 37 ºC for 5 minutes. To this, E. coli PurC (13.5 µg) was added
along with PurK (0 or 11.5 µg) and WT or mutant PurE (6U). The reaction was
initiated by adding 60 µM AIR and SAICAR synthesis was monitored at 282
nm.9,10,45
3.8

Thermoflour®
In a 0.2 mL PCR tube, 10 mM HEPES (pH7.5) buffer was added along

with150 mM NaCL, 5X SYPRO Orange, and 75 µg/ml of E.coli PurE, (0-1mM)
AIR

or,

1-(4-ethoxyphenyl)-3-[(3-pyridinylmethyl)amino]-2,5-pyrrolidinedione
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(ChemBridge Corporation). The final volume was 30 µL, Thermal melting was
done using a RT-PCR instrument from 25-95 ºC while monitoring fluorescence
of SYPRO orange (ex=492 nm, em=610 nm). The melting temperature was
calculated from the maximum of first derivate curve.39 For studies of ligand
induced changed in the Tm, the same experiment was repeated in the
presence of various concentrations of ligand.
3.9

Metal stopping assay.
In a final volume of 1mL containing 50 mM Tris-HCl (pH 7) buffer, 250

µM CAIR or AIR was added along with E.coli PurE (0-3 µg) and the reaction
was incubated at room temperature for 10 minutes. The reaction was
quenched by the addition of 250 µM ZnSO4 and fluorescence was determined
from 400-600 nm while being excited at 360nm. The same concentration and
method was applied to a 96-well microplate using a 100 µL per well final
volume. Fluorescence data was collected using the Multi-Mode Microplate
Reader (Synergy) with the excitation filter set at 360 nm and the emission filter
set at 485 nm.41
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ABSTRACT
Site-Directed Mutagenesis of Conserved Amino Acids Residues in N5Carboxyaminoimidazole Ribonucleotide Mutase
&
Developing a High-Throughput Screen Assay for the Discovery of N5Carboxyaminoimidazole Ribonucleotide Mutase Inhibitors
by
ZHIWEN SHI
July 2014
Advisor: Dr. Steven M. Firestine
Major: Pharmaceutical Sciences
Degree: Master of Science
The de novo purine biosynthesis pathway plays a critical role in
providing new purines to the cell. Previous studies have shown differences
between the human and bacterial pathways which suggests that pathway may
be a potential target for antibiotic drug discovery. Three critical enzymes are
involved in the pathway divergence. In the bacterial pathway, N5-CAIR
synthetase (PurK) first converts AIR to N5-CAIR, which is then transformed into
CAIR catalyzed by the enzyme N5-CAIR mutase (Class I PurE). In the human
pathway, AIR carboxylase (Class II PurE) catalyzes the direct conversion of
AIR to CAIR. Class I and Class II PurEs have structure and sequence
similarities but also are functionally different. However, the residues
responsible for these differences are unknown. In this study, we hypnotized
that the class-specific conserved residues in the active site might be the key to
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determining the functional differences between the two PurEs. Site-directed
mutagenesis was used to convert residues of Class I PurEs to Class II PurEs.
Several mutant PurEs were made and examined for CO2-dependent
conversion of AIR to CAIR. Two mutants H71A and H71G displayed CO2
dependent that was similar to that observed for AIR carboxylase. Additional
studies revealed that these enzymes also were capable of using N5-CAIR as a
substrate. This indicates that the H71A and H71G mutant have AIR
carboxylase as well as N5-CAIR mutase activity. Examination of the crystal
structure of N5-CAIR mutase indicates that His71 is at the bottom of the active
site and removal of this residue creates a channel between active sites in two
subunits. We speculate that this channel may be key for the utilization of CO2.
The second project focused on developing an appropriate highthroughput screening (HTS) assay for Class I PurE inhibitor. Existing assays
have significant issue for HTS. We examined both a thermo shift assay as well
as a metal stopping/fluorescence assay. While both assays had some potential
issues for analysis indicated that neither assay was suitable for HTS.
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